Alpha-halocarboxylic acids and derivatives
Selleck Chemical LLC BIBO 3304 Trifluoroacetate
BIBO 3304 Trifluoroacetate (BIBO-3304 TFA) is a novel neuropeptide Y Y1 receptor (NPY1R) antagonist with IC50 values of 0 38 nM and 0 72 nM for human Y1 receptor and rat Y1 receptor respectively BIBO 3304 shows low affinity for the human Y2 receptor human and rat Y4 receptor as well as for the human and rat Y5 receptor (IC50 values 1000 nM)
AdipoGen Rhodamine 6G p-DAX amide bis
Chemical. CAS 591742-78-8. Formula C34H36N4O2 . C4H2F6O4. MW 760.72. Synthetic. Fluorescent labelling.
TARGETMOL CHEMICALS INC XMD-17-51 Trifluoroacetate 5MG
Also available in 1 mL, 1 mg, 10 mg, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. XMD-17-51 Trifluoroacetate is a pyrimido-diazepinone compound that regulates protein kinases. Purity 99.65%
Selleck Chemical LLC RR82 Trifluoroacetate Salt
Pyridostatin Trifluoroacetate Salt is a G-quadruplexe stabilizer with Kd of 490 nM in a cell-free assay which targets a series of proto-oncogenes
Strem, An Ascensus Company CAS# 383-63-1. 25g. Ethyltrifluoroacetate, 99%. MFCD00000419
CAS# 383-63-1. 25g. Ethyltrifluoroacetate, 99%. MFCD00000419. Molecular Weight: 142.08. Molecular Formula: CF3CO2C2H5. Color/form: colorless liq. Strem# 09-3270. http://www.strem.com/catalog/v/09-3270/
eMolecules 42014-51-7 | Bromoacetic acid N-hydroxysuccinimide ester | Ambeed | MFCD00058571 | 236.021 | C6H6BrNO4 | 98.000 | BrCC(=O)ON1C(=O)CCC1=O | 5g | 491682977
Bromoacetic acid N-hydroxysuccinimide ester | Ambeed | 42014-51-7 | MFCD00058571 | 236.021 | C6H6BrNO4 | 98.000 | BrCC(=O)ON1C(=O)CCC1=O | 5g | 491682977
Cambridge Isotope Laboratories Tauro-beta-muricholic acid sodium salt (unlabeled) CP 95% 10 mg
Tauro-beta-muricholic acid sodium salt (unlabeled) CP 95% 10 mg
eMolecules 1878-67-7 | M-BROMOPHENYLACETIC ACID | AstaTech | MFCD00004330 | 215.046 | C8H7BrO2 | 98.000 | OC(=O)Cc1cccc(Br)c1 | 500g | 206682072
M-BROMOPHENYLACETIC ACID | AstaTech | 1878-67-7 | MFCD00004330 | 215.046 | C8H7BrO2 | 98.000 | OC(=O)Cc1cccc(Br)c1 | 500g | 206682072
eMolecules 1878-67-7 | 2-(3-Bromophenyl)acetic acid | Synthonix | MFCD00004330 | 215.046 | C8H7BrO2 | 95.000 | OC(=O)Cc1cccc(Br)c1 | 10g | 779537876
2-(3-Bromophenyl)acetic acid | Synthonix | 1878-67-7 | MFCD00004330 | 215.046 | C8H7BrO2 | 95.000 | OC(=O)Cc1cccc(Br)c1 | 10g | 779537876
eMolecules 1878-67-7 | 3-Bromophenylacetic acid | Ambeed | MFCD00004330 | 215.046 | C8H7BrO2 | 98.000 | OC(=O)Cc1cccc(Br)c1 | 100g | 525119029
3-Bromophenylacetic acid | Ambeed | 1878-67-7 | MFCD00004330 | 215.046 | C8H7BrO2 | 98.000 | OC(=O)Cc1cccc(Br)c1 | 100g | 525119029
eMolecules 401-67-2 | DIFLUOROACETIC ANHYDRIDE | AstaTech | MFCD02093315 | 174.051 | C4H2F4O3 | 95.000 | FC(F)C(=O)OC(=O)C(F)F | 100g | 586045903
DIFLUOROACETIC ANHYDRIDE | AstaTech | 401-67-2 | MFCD02093315 | 174.051 | C4H2F4O3 | 95.000 | FC(F)C(=O)OC(=O)C(F)F | 100g | 586045903
eMolecules 42014-51-7 | Bromoacetic acid N-hydroxysuccinimide ester | Combi-Blocks | MFCD00058571 | 236.021 | C6H6BrNO4 | 97.000 | BrCC(=O)ON1C(=O)CCC1=O | 25g | 415497752
Bromoacetic acid N-hydroxysuccinimide ester | Combi-Blocks | 42014-51-7 | MFCD00058571 | 236.021 | C6H6BrNO4 | 97.000 | BrCC(=O)ON1C(=O)CCC1=O | 25g | 415497752
Medchemexpress LLC Acetic acid, 2-iodo-, 1,1'-anhydride | 54907-61-8 | MFCD00001080 | 70.0% | 353.88 g·mol-1 | C4H4I2O3 | 100 MG
Iodoacetic anhydride is the 2-iodo derivative of acetic anhydride used as a reagent in chemical synthesis and biochemical research. It is supplied as a brown to dark brown solid with molecular formula C4H4I2O3 and molecular weight 353.88 g·mol-1.
- Molecular formula: C4H4I2O3
- Molecular weight: 353.88 g·mol-1
- Appearance: Brown to dark brown solid
- Cas number: 54907-61-8
- Typical pack size: 100 MG
- Purity (batch example): 70.0% (NMR)
AdipoGen GE23077 A1 B1
Chemical. CAS 752989-46-1, 752989-45-0752989-44-9. Formula C31H51N9O16, C31H49N9O16. MW 805.8803.8. Isolated from Actinomadura sp. Cyclic heptapeptide antibiotic. Potent and selective inhibitor of bacterial RNA polymerase RNAP. Inhibits Gram-positive Bacillus subtilis and Gram-negative Escherichia coli RNAPs with IC50 ~20nM, whereas it is not active on E. coli DNA polymerase or on eukaryotic wheat germ RNAP II IC50 values >100µM. Even though of its potent activity in vitro on purified bacterial RNAPs, it shows a narrow spectrum of antimicrobial activity in vivo on Gram-positive and Gram-negative bacteria, due to lack of memmbrane permeability. Acts at the level of transcription initiation. Binds directly to the bacterial RNA polymerase RNAP active-center i and i1 nucleotide binding sites, preventing the binding of initiating nucleotides and thereby preventing transcription initiation.
Cayman Chemical W146 trifluoroacetate salt
An S1P1 receptor antagonist (Ki = 77 nM); selective for S1P1 over S1P2, S1P3, and S1P5 (Kis = >10 µM); prevents ligand-induced receptor internalization in CHO cells and inhibits ERK and Akt phosphorylation at 10 µM; increases AMD3100-induced KSL-HSPC entrance into mouse blood circulation from the bone marrow at 5 mg/kg in combination with AMD3100; disrupts the endothelial barrier and induces PMN neutrophil infiltration into the lungs and skin in an ovalbumin-induced mouse model of immune cell-mediated vascular injury at 10 UG intranasally or intradermally